Sickle cell disease
Sickle cell disease is an inherited blood disorder that affects red blood cells. People with sickle cell disease have red blood cells that contain mostly hemoglobin* S, an abnormal type of hemoglobin. Sometimes these red blood cells become sickle-shaped (crescent shaped) and have difficulty passing through small blood vessels. When sickle-shaped cells block small blood vessels, less blood can reach that part of the body. Tissue that does not receive a normal blood flow eventually becomes damaged. This is what causes the complications of sickle cell disease. There is currently no universal cure for sickle cell disease. Health maintenance for patients with sickle cell disease starts with early diagnosis, preferably in the newborn period and includes penicillin prophylaxis, vaccination against pneumococcus bacteria and folic acid supplementation.
Treatment of complications often includes antibiotics, pain management, intravenous fluids, blood transfusion and surgery all backed by psychosocial support. Like all patients with chronic disease patients are best managed in a comprehensive multi-disciplinary program of care.
Grants related to the topic: Sickle cell disease
- MRI-based quantitative brain oxygen metabolism mapping in sickle cell anemia
PI: Jordan, Lori
- MRI-based quantitative brain oxygen metabolism identifying high risk of infarc in sickle cell anemia
PI: Jordan, Lori
People related to the topic: Sickle cell disease
Bruce Compas, Ph.D.
Patricia and Rodes Hart Professor of Psychology and Human Development; Professor of Pediatrics; Director, Psycho-Oncology, Vanderbilt-Ingram Cancer Center
Lori Jordan, M.D., Ph.D.
Assistant Professor of Neurology, Division of Pediatric Neurology
Back to the topic index